Trial Profile
Retrospective Survey of Bone Fracture in Post-Menopausal Breast Cancer Patients With Arimidex 1 mg as Adjuvant Therapy.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 12 Mar 2009 New trial record